Skip to main content

Hernia Mesh Lawsuit: Court Outlines Trial Schedule

Hernia Mesh Lawsuit: Court Outlines Trial Schedule

Hernia Mesh Lawsuit: Court Outlines Trial Schedule

Introduction

The U.S. District Judge Edmund A. Sargus has outlined the process for selecting cases to go to trial for several pending Bard hernia mesh cases.

According to the case management order issued earlier this month, the cases will guide the parties on how juries will respond to certain evidence that will be repeated throughout. Six cases designed to be representative of allegations went through pretrial discovery, which included three claims initially selected by each side.

On January 3, 2020, both the parties will file their respective briefs. By January 8, each side will be allowed to file a response to the other side’s proposed cases, which will be followed by an in-person status conference on January 10 for final selections and trial schedules. In case of dismissal of the three cases, replacement cases by either party will be selected. Following the selection, the parties must file any dispositive motions and Daubert challenges by January 17, 2020, with oral arguments to be scheduled at a later date.

Trials will begin on the following dates for the selected cases:

  • May 11, 2020

  • July 13, 2020

  • September 14, 2020  

The selected cases will decide the fate of the remaining lawsuits. More than 3,500 Bard hernia mesh claims are consolidated under federal multidistrict litigation (MDL No. 2846; In Re: Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation) in the Southern District of Ohio, presided by Honorable Edmund A. Sargus, Jr., and Honorable Kimberly A. Jolson.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!